½ÃÀ庸°í¼­
»óǰÄÚµå
1472058

¹Ì±¹ÀÇ ¹é³»Àå ½ÃÀå(2024³â) : MedOp Index ºÐ¼®

2024 United States Cataract Atlas Featuring the Market Scope Exclusive MedOp Index Analysis

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Market Scope, LLC | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ÀÌ º¸°í¼­´Â ¹Ì±¹ÀÇ ¹é³»Àå ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ¹Ì±¹ 85°³ µµ½Ã Áö¿ªÀÇ ±âÁ¸ ¹é³»Àå ¼ö¼ú°ú ÇÁ¸®¹Ì¾ö ¹é³»Àå ¼ö¼úÀÇ ±âȸ¸¦ Áö¿ªº°·Î ºÐ¼®ÇÕ´Ï´Ù. Áö¿ªº° ½ÃÀå ±âȸ, ÃֽŠÃßÁ¤ ¼ö¼ú °Ç¼ö ¹× ȯÀÚ Àα¸Åë°è µ¥ÀÌÅÍ, Àα¸Åë°èÇÐÀû ÇÁ·ÎÆÄÀÏ µîÀÇ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

  • MedOp Index(TM) ºÐ¼® ¼øÀ§¿Í µµ½Ã±Ç ¹× Áö¿ª¿¡ ´ëÇÑ º¥Ä¡¸¶Å©
  • ¿Ü°úÀÇ °³¿ä : Áõ·Ê ¼öÄ«Å×°í¸®º° ¿Ü°úÀÇ ¼ö ¹× Æò±Õ ¿¬°£ ¾È³» ·»Áî ¼ö¼ú Áõ·Ê ¼ö
  • ASC °³¿ä : Ä«Å×°í¸®º° ASC¼ö ¹× ´ëµµ½Ã±Ç ASC ±Ùó Æò±Õ ¿¬°£ ¼ö¼ú °Ç¼ö
  • ¼ö¼ú °³¿ä : À¯Çüº° ¾È³» ·»Áî ¼ö¼ú °Ç¼ö ¹× ÇÁ¸®¹Ì¾ö ¼ö¼úÀ²
  • FLACS¸¦ ±¤°íÇϰí ÀÖ´Â ÀÇ·á±â°ü ¼ö
  • MedOp Index(TM) ºÐ¼® : ÁÖ¿ä ȯÀÚ Àα¸Åë°è(¿¬·ÉÃþº° Àα¸, ºÎÀ¯Ãþ, °Ç°­ »óÅÂ) ¹× ¹é³»Àå ¿Ü°úÀÇ ¼ö¿Í ÁýÁßµµ
  • Àα¸Åë°è °³¿ä : ¿¬·É´ëº° Àα¸, ±âȸ Àα¸, ÀÇ»ç Àα¸, ¿¬·É Áß¾ÓÄ¡, °¡°è¼Òµæ Áß¾ÓÄ¡
  • ³­½Ã Àα¸ : ¿¬·ÉÃþº° Àα¸¿Í ÁßÁõµµº° Àα¸
LSH 24.05.08

What's New:

The "2024 United States Cataract Atlas" features a new directory of practices offering cataract surgery, with a filter to easily navigate to practices with co-located ASCs. The new atlas includes updated procedure volume estimates and patient demographic data, in addition to state and regional aggregates of all key metrics.

The "2024 United States Cataract Atlas" provides a geographic analysis of the conventional and premium cataract surgery opportunity in 85 US metropolitan areas. Market Scope's proprietary MedOp Index(TM) Analysis examines market potential and provides a benchmark against other metros. The atlas offers strategic insights into the top potential markets in the US, which companies often use throughout the development and commercialization processes to identify ideal clinical trial locations, develop launch strategies, define sales territories, allocate resources, and optimize sales and marketing initiatives.

Contents:

The atlas offers an in-depth examination of IOL opportunity, and Market Scope's MedOp Index(TM) Analysis integrates multiple variables to illustrate US market opportunity by metro area. The following information is included for 85 metropolitan areas:

  • MedOp Index(TM) Analysis ranking and benchmark against metros and region
  • Surgeon profiles: count of surgeons by volume category (ultra-high, high, medium, low) and average annual IOL procedure volumes
  • ASC profiles: count of ASCs by volume category, and average annual procedures per ASC per metropolitan area
  • Procedure profiles: IOL procedure count by type (conventional, premium, RLE) and premium procedure rate
  • Count of practices advertising FLACS
  • MedOp Index(TM) Analysis detail: key patient demographics (population by age groups, wealth, health) and volume and concentration of cataract surgeons
  • Demographic profiles: population by age group, high opportunity population, pseudophakics, median age, and median household income
  • Astigmatism population: population by age group and severity

Author Profile:

Chelsea Jones, MBA

Chelsea has over 10 years of experience as an analyst in multiple medical verticals.

After receiving her MBA, Chelsea began her career at Cerner Corporation, the leading supplier of healthcare information technology solutions, where she performed many analytical roles in the Population Health organization. She also has experience in crafting and executing competitive intelligence strategy, product development, and market opportunity assessment.

Chelsea authors the global ophthalmic laser report, the global refractive report, the global cornea report, the ophthalmic deals book, the US cataract atlas,the US refractive atlas, the US glaucoma atlas, and the US dry eye atlas. She is also a contributor to Market Scope's Ophthalmic Market Perspectives monthly industry newsletter.

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦